PDCI and 3Sixty Public Affairs invites its industry clients, partners and colleagues to participate in a webinar on September 4, 2019 between 2:00pm to 3:00pm. This important session will cover the PMPRB price regulatory amendments and share insights on their implications for pharmaceutical market access.
The session will provide an overview of PMPRB amendments and their expected impact on current and future patented medicines in Canada. Senior PDCI staff and our partners at 3Sixty Public Affairs will provide insight into the changes to the Regulations, questions still to be answered in the Draft Guidelines, and the industry legal challenges to the changes.
Note: a pharmaceutical company email address is required to register and attend the webinar.
Please sign up for the free session here.